Inozyme Pharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Inozyme Pharma and buy or sell other stocks, ETFs, and their options commission-free!

About INZY

Inozyme Pharma, Inc. is a clinical-stage rare disease biopharmaceutical company. It engages in the business of developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton. 

CEO
Doug Treco Treco, PhD
CEODoug Treco Treco, PhD
Employees
67
Employees67
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2015
Founded2015
Employees
67
Employees67

INZY Key Statistics

Market cap
258.25M
Market cap258.25M
Price-Earnings ratio
-2.38
Price-Earnings ratio-2.38
Dividend yield
Dividend yield
Average volume
1.06M
Average volume1.06M
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$6.24
52 Week high$6.24
52 Week low
$0.721
52 Week low$0.721

People also own

Based on the portfolios of people who own INZY. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.